(PDF) Safety Profile of Biologic Therapy in Polish

Safety Profile of Biologic Therapy in Polish Paediatric Patients With Crohn’s Disease

Przeglad Gastroenterologiczny - Poland

doi 10.5114/pg.2015.52298

Full Text

Abstract

Available in full text

Categories

Gastroenterology

Date

January 1, 2015

Authors

Edyta Szymanska

Maciej Dadalski

Jarosław Kierkus

Publisher

Termedia Sp. z.o.o.

Related search

Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Digestive Diseases and Sciences

Gastroenterology

English

Pgi41 - Clinical Characteristics of Biologic Treated Crohn’s Disease Patients With and Without Prior Surgery in European Union

Value in Health

Occupational Health

English

Adalimumab for Endoscopic and Histopathological Mucosal Healing in Paediatric Patients With Moderate to Severe Crohn’s Disease

Przeglad Gastroenterologiczny

Gastroenterology

English

Safety and Tolerability of Low-Dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease

Journal of Clinical Gastroenterology

Gastroenterology

English

Efficacy of Biologic Therapy in Patients With Chronic Pouchitis

International Journal of Colorectal Disease

Gastroenterology

English

Efficiency and Safety of One-Year Anti-TNF-Α Treatment in Crohn’s Disease: A Polish Single-Centre Experience

Przeglad Gastroenterologiczny

Gastroenterology

English

Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy

Arthritis Care and Research

English

Outcomes of Non-Infectious Paediatric Uveitis in the Era of Biologic Therapy

Pediatric Rheumatology

English

Characterizing Unmet Medical Need and the Potential Role of New Biologic Treatment Options in Patients With Ulcerative Colitis and Crohn’s Disease

European Journal of Gastroenterology and Hepatology

Gastroenterology

English